Roth-Isigkeit A, Brechmann J, Dibbelt L, Sievers H H, Raasch W, Schmucker P
Department of Anesthesia, Medical University of Luebeck, Germany.
J Endocrinol Invest. 1998 Jan;21(1):12-9. doi: 10.1007/BF03347280.
To investigate the endocrine stress response in patients undergoing major surgery with general anesthesia using a balanced technique with sufentanil, isoflurane and midazolam up to the second postoperative day, blood levels of cortisol, epinephrine, norepinephrine, prolactin and growth hormone were determined in 68 males for elective coronary artery bypass grafting (CABG) surgery. Intraoperatively, during extracorporeal circulation none of the measured parameters were significantly increased compared to preoperative values. The endocrine response of patients with perioperative epinephrine medication (n = 32) was not significant different to patients that did not receive exogenous epinephrine (n = 36). On the evening of the day of surgery, levels of cortisol (3 fold), epinephrine (4.7 fold), norepinephrine (1.7 fold) and growth hormone (16.5 fold) were significantly increased. Compared to preoperative values levels of cortisol (3.3 fold), growth hormone (5.5 fold) and norepinephrine (1.8 fold) remained elevated up to the evening of the second postoperative day. In conclusion, the endocrine stress response in patients undergoing CABG-surgery under general anesthesia with sufentanil, midazolam, isoflurane is intraoperatively prevented by anesthesia. Although hemodilution or hormone degradation might be responsible for the lack of an increase in endocrine parameters during CPB, this study indicates that a balanced technique with isoflurane, sufentanil and midazolam is more effective in blocking the endocrine stress response than previously described anesthetic techniques. In the early postoperative period, a sharp increase in cortisol, epinephrine, norepinephrine and growth hormone occurred suggesting that the predominant endocrine stress response begins in the intensive care unit with end of anesthesia. The postoperative elevated levels of cortisol, growth hormone and norepinephrine indicate a persisting stress-response for more than two days after surgical trauma.
为研究在使用舒芬太尼、异氟烷和咪达唑仑的平衡技术进行全身麻醉的大手术患者中,直至术后第二天的内分泌应激反应,对68例择期冠状动脉搭桥术(CABG)的男性患者测定了皮质醇、肾上腺素、去甲肾上腺素、催乳素和生长激素的血药浓度。术中,在体外循环期间,与术前值相比,所测参数均未显著升高。围手术期使用肾上腺素的患者(n = 32)与未接受外源性肾上腺素的患者(n = 36)的内分泌反应无显著差异。手术当天晚上,皮质醇(3倍)、肾上腺素(4.7倍)、去甲肾上腺素(1.7倍)和生长激素(16.5倍)水平显著升高。与术前值相比,直至术后第二天晚上,皮质醇(3.3倍)、生长激素(5.5倍)和去甲肾上腺素(1.8倍)水平仍保持升高。总之,在全身麻醉下使用舒芬太尼、咪达唑仑、异氟烷进行CABG手术的患者,术中麻醉可防止内分泌应激反应。尽管血液稀释或激素降解可能是体外循环期间内分泌参数未升高的原因,但本研究表明,与先前描述的麻醉技术相比,异氟烷、舒芬太尼和咪达唑仑的平衡技术在阻断内分泌应激反应方面更有效。在术后早期,皮质醇、肾上腺素、去甲肾上腺素和生长激素急剧增加,表明主要的内分泌应激反应始于麻醉结束后的重症监护病房。术后皮质醇、生长激素和去甲肾上腺素水平升高表明手术创伤后应激反应持续超过两天。